View of Preparation of (177Lu-DOTA)n-PAMAM-[Nimotuzumab-F(abâ)2] as a Therapeutic Radioimmunoconjugate for EGFR Overexpressed Cancers Treatment

Return to Article Details Preparation of (177Lu-DOTA)n-PAMAM-[Nimotuzumab-F(abâ)2] as a Therapeutic Radioimmunoconjugate for EGFR Overexpressed Cancers Treatment Download Download PDF